Nothing Special   »   [go: up one dir, main page]

Lapolla et al., 2022 - Google Patents

Proteomic approaches in the study of placenta of pregnancy complicated by gestational diabetes mellitus

Lapolla et al., 2022

View HTML
Document ID
3993574776157977129
Author
Lapolla A
Traldi P
Publication year
Publication venue
Biomedicines

External Links

Snippet

Gestational diabetes mellitus (GDM), a glucose intolerance developing or first recognized during pregnancy, leads to a series of short-and long-term maternal and fetal complications, somehow related to placenta structural and functional changes. The focus and the objective …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/28—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for programming tools or database systems, e.g. ontologies, heterogeneous data integration, data warehousing or computing architectures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
    • G06Q50/10—Services
    • G06Q50/22—Health care, e.g. hospitals; Social work

Similar Documents

Publication Publication Date Title
Rysz et al. Novel biomarkers in the diagnosis of chronic kidney disease and the prediction of its outcome
Panner Selvam et al. Sperm proteome analysis and identification of fertility-associated biomarkers in unexplained male infertility
Ahn et al. Differential urinary proteome analysis for predicting prognosis in type 2 diabetes patients with and without renal dysfunction
Bielfeld et al. A proteome approach reveals differences between fertile women and patients with repeated implantation failure on endometrial level—does hCG render the endometrium of RIF patients?
Mun et al. Proteomics approach for the discovery of rheumatoid arthritis biomarkers using mass spectrometry
Lee et al. Sarcopenia index as a predictor of clinical outcomes in older patients with coronary artery disease
Corasolla Carregari et al. Proteomics of muscle microdialysates identifies potential circulating biomarkers in facioscapulohumeral muscular dystrophy
Hajduk et al. A combined metabolomic and proteomic analysis of gestational diabetes mellitus
Mohamad et al. A review of candidate genes and pathways in preeclampsia–an integrated bioinformatical analysis
Levstek et al. Biomarkers of Fabry nephropathy: review and future perspective
Füvesi et al. Proteomic analysis of cerebrospinal fluid in a fulminant case of multiple sclerosis
Zancolli et al. Venom on-a-chip: A fast and efficient method for comparative venomics
Wendt et al. Molecular mapping of urinary complement peptides in kidney diseases
Chantada-Vázquez et al. Proteomics in inherited metabolic disorders
Álvarez et al. Characterization of new proteomic biomarker candidates in mucopolysaccharidosis type IVA
Seok et al. Identification and validation of SAA4 as a rheumatoid arthritis prescreening marker by liquid chromatography tandem-mass spectrometry
Saptarshi et al. Epigenetic age acceleration is not associated with age-related macular degeneration
Baker et al. Newborn screening for X-linked adrenoleukodystrophy in Nebraska: initial experiences and challenges
Rafiullah et al. Urinary proteome differences in patients with type 2 diabetes pre and post liraglutide treatment
Hohenfellner et al. Newborn screening: review of its impact for cystinosis
Olianas et al. Top-Down proteomics detection of potential salivary biomarkers for autoimmune liver diseases classification
Muiño et al. RP11-362K2. 2: RP11-767I20. 1 genetic variation is associated with post-reperfusion therapy parenchymal hematoma. A GWAS meta-analysis
Jiang et al. Head-to-head comparison of different blood collecting tubes for quantification of Alzheimer’s disease biomarkers in plasma
Ghelani et al. Can coronary artery involvement in Kawasaki disease be predicted?
Fernandez-Encinas et al. Proteomic analysis in seminal plasma of fertile donors and infertile patients with sperm DNA fragmentation